Skip to main content
Top
Published in: International Journal of Legal Medicine 5/2007

01-09-2007 | Original Article

Carisoprodol intoxications: a retrospective study of forensic autopsy material from 1992–2003

Authors: Gudrun Høiseth, Jørgen G. Bramness, Asbjørg S. Christophersen, Jørg Mørland

Published in: International Journal of Legal Medicine | Issue 5/2007

Login to get access

Abstract

Carisoprodol is commonly prescribed as a centrally acting muscle relaxant, but it is also subject to abuse. The literature describing fatal intoxications with the drug is limited to a relatively small number of cases, and there are inconsistencies with regard to which concentration levels that are toxic. We therefore investigated all forensic autopsies at the Norwegian Institute of Public Health during the period 1992–2003 where carisoprodol was detected. The median concentrations of carisoprodol in intoxication with carisoprodol only or with only minor other analytical findings was 36 mg/l (range 8–65 mg/l; n=5). In the rest of the intoxications, the relevance of carisoprodol relative to the other drugs detected was variable (n=93). When the number of intoxications with carisoprodol each year were divided by the number of defined daily doses (DDD) sold, a fatal toxicity index between 5.6 and 6.9 deaths/1 million DDD was obtained. The total number of cases where carisoprodol was detected increased during the period studied, which correlated to sales figures for the drug. We conclude that carisoprodol can be fatal in concentrations below those indicated in some of the previously published literature. There were, however, only a small number of cases where the cause of death can be attributed to use of carisoprodol alone.
Literature
1.
go back to reference Dalen P, Alvan G, Wakelkamp M, Olsen H (1996) Formation of meprobamate from carisoprodol is catalysed by CYP2C19. Pharmacogenetics 6:387–394PubMedCrossRef Dalen P, Alvan G, Wakelkamp M, Olsen H (1996) Formation of meprobamate from carisoprodol is catalysed by CYP2C19. Pharmacogenetics 6:387–394PubMedCrossRef
2.
go back to reference van Tulder MW, Touray T, Furlan AD, Solway S, Bouter LM (2003) Muscle relaxants for nonspecific low back pain: a systematic review within the framework of the cochrane collaboration. Spine 28:1978–1992PubMedCrossRef van Tulder MW, Touray T, Furlan AD, Solway S, Bouter LM (2003) Muscle relaxants for nonspecific low back pain: a systematic review within the framework of the cochrane collaboration. Spine 28:1978–1992PubMedCrossRef
3.
go back to reference Hindle TH III (1972) Comparison of carisoprodol, butabarbital, and placebo in treatment of the low back syndrome. Calif Med 117:7–11PubMed Hindle TH III (1972) Comparison of carisoprodol, butabarbital, and placebo in treatment of the low back syndrome. Calif Med 117:7–11PubMed
4.
go back to reference Boyles W, Glassmann J, Soyka J (1983) Management of acute muskuloskeletal conditions: thoracolumbar strain and pain. A double-blind evaluation comparing the efficacy and safety of carisoprodol with diazepam. Today’s Ther Trends 1:1–16 Boyles W, Glassmann J, Soyka J (1983) Management of acute muskuloskeletal conditions: thoracolumbar strain and pain. A double-blind evaluation comparing the efficacy and safety of carisoprodol with diazepam. Today’s Ther Trends 1:1–16
5.
go back to reference Rollings H, Glassmann J, Soyka J (1982) Management of acute muskuloskeletal conditions—thoracolumbar strain and sprain: a double-blind evaluation comparing the efficacy and safety of carisoprodol with cyclobenzadrine hydrochloride. Curr Ther Res 34:917–928 Rollings H, Glassmann J, Soyka J (1982) Management of acute muskuloskeletal conditions—thoracolumbar strain and sprain: a double-blind evaluation comparing the efficacy and safety of carisoprodol with cyclobenzadrine hydrochloride. Curr Ther Res 34:917–928
6.
go back to reference Boothby L, Doering P, Hatton R (2003) Carisoprodol: a marginally effective skeletal muscle relaxant with serious abuse potential. Hosp Pharm 38:337–345 Boothby L, Doering P, Hatton R (2003) Carisoprodol: a marginally effective skeletal muscle relaxant with serious abuse potential. Hosp Pharm 38:337–345
7.
go back to reference Wyller TB, Korsmo G, Gadeholt G (1991) Dependence on carisoprodol (Somadril)? A prospective withdrawal study among prisoners [Avhengig av karisoprodol (Somadril)? En prospektiv seponeringsundersøkelse blant fengselsinnsatte]. Tidsskr Nor Laegeforen 111:193–195PubMed Wyller TB, Korsmo G, Gadeholt G (1991) Dependence on carisoprodol (Somadril)? A prospective withdrawal study among prisoners [Avhengig av karisoprodol (Somadril)? En prospektiv seponeringsundersøkelse blant fengselsinnsatte]. Tidsskr Nor Laegeforen 111:193–195PubMed
8.
go back to reference Reeves RR, Carter OS, Pinkofsky HB, Struve FA, Bennett DM (1999) Carisoprodol (soma): abuse potential and physician unawareness. J Addict Dis 18:51–56PubMedCrossRef Reeves RR, Carter OS, Pinkofsky HB, Struve FA, Bennett DM (1999) Carisoprodol (soma): abuse potential and physician unawareness. J Addict Dis 18:51–56PubMedCrossRef
9.
go back to reference Bailey DN, Briggs JR (2002) Carisoprodol: an unrecognized drug of abuse. Am J Clin Pathol 117:396–400PubMedCrossRef Bailey DN, Briggs JR (2002) Carisoprodol: an unrecognized drug of abuse. Am J Clin Pathol 117:396–400PubMedCrossRef
10.
go back to reference Sikdar S, Basu D, Malhotra AK, Varma VK, Mattoo SK (1993) Carisoprodol abuse: a report from India. Acta Psychiatr Scand 88:302–303PubMed Sikdar S, Basu D, Malhotra AK, Varma VK, Mattoo SK (1993) Carisoprodol abuse: a report from India. Acta Psychiatr Scand 88:302–303PubMed
11.
go back to reference Bramness JG, Morland J, Sorlid HK, Rudberg N, Jacobsen D (2005) Carisoprodol intoxications and serotonergic features. Clin Toxicol 43:39–45 Bramness JG, Morland J, Sorlid HK, Rudberg N, Jacobsen D (2005) Carisoprodol intoxications and serotonergic features. Clin Toxicol 43:39–45
12.
go back to reference Siddiqi M, Jennings CA (2004) A near-fatal overdose of carisoprodol (SOMA): case report. J Toxicol Clin Toxicol 42:239–240PubMedCrossRef Siddiqi M, Jennings CA (2004) A near-fatal overdose of carisoprodol (SOMA): case report. J Toxicol Clin Toxicol 42:239–240PubMedCrossRef
13.
go back to reference Roth BA, Vinson DR, Kim S (1998) Carisoprodol-induced myoclonic encephalopathy. J Toxicol Clin Toxicol 36:609–612PubMedCrossRef Roth BA, Vinson DR, Kim S (1998) Carisoprodol-induced myoclonic encephalopathy. J Toxicol Clin Toxicol 36:609–612PubMedCrossRef
14.
go back to reference Roberge RJ, Lin E, Krenzelok EP (2000) Flumazenil reversal of carisoprodol (Soma) intoxication. J Emerg Med 18:61–64PubMedCrossRef Roberge RJ, Lin E, Krenzelok EP (2000) Flumazenil reversal of carisoprodol (Soma) intoxication. J Emerg Med 18:61–64PubMedCrossRef
15.
go back to reference Roache JD, Griffiths RR (1987) Lorazepam and meprobamate dose effects in humans: behavioral effects and abuse liability. J Pharmacol Exp Ther 243:978–988PubMed Roache JD, Griffiths RR (1987) Lorazepam and meprobamate dose effects in humans: behavioral effects and abuse liability. J Pharmacol Exp Ther 243:978–988PubMed
16.
go back to reference Winek CL, Wahba WW, Winek CL Jr, Balzer TW (2001) Drug and chemical blood-level data 2001. Forensic Sci Int 122:107–123PubMedCrossRef Winek CL, Wahba WW, Winek CL Jr, Balzer TW (2001) Drug and chemical blood-level data 2001. Forensic Sci Int 122:107–123PubMedCrossRef
17.
go back to reference Druid H, Holmgren P (1997) A compilation of fatal and control concentrations of drugs in postmortem femoral blood. J Forensic Sci 42:79–87PubMed Druid H, Holmgren P (1997) A compilation of fatal and control concentrations of drugs in postmortem femoral blood. J Forensic Sci 42:79–87PubMed
18.
go back to reference Chung H, Park M, Hahn E, Choi H, Choi H, Lim M (2004) Recent trends of drug abuse and drug-associated deaths in Korea. Ann N Y Acad Sci 1025:458–464PubMedCrossRef Chung H, Park M, Hahn E, Choi H, Choi H, Lim M (2004) Recent trends of drug abuse and drug-associated deaths in Korea. Ann N Y Acad Sci 1025:458–464PubMedCrossRef
19.
go back to reference Backer RC, Zumwalt R, McFeeley P, Veasey S, Wohlenberg N (1990) Carisoprodol concentrations from different anatomical sites: three overdose cases. J Anal Toxicol 14:332–334PubMed Backer RC, Zumwalt R, McFeeley P, Veasey S, Wohlenberg N (1990) Carisoprodol concentrations from different anatomical sites: three overdose cases. J Anal Toxicol 14:332–334PubMed
20.
go back to reference Adams HR, Kerzee T, Morehead CD (1975) Carisoprodol-related death in a child. J Forensic Sci 20:200–202PubMed Adams HR, Kerzee T, Morehead CD (1975) Carisoprodol-related death in a child. J Forensic Sci 20:200–202PubMed
21.
go back to reference Davis GG, Alexander CB (1998) A review of carisoprodol deaths in Jefferson County, Alabama. South Med J 91:726–730PubMed Davis GG, Alexander CB (1998) A review of carisoprodol deaths in Jefferson County, Alabama. South Med J 91:726–730PubMed
22.
go back to reference Ronning M (2001) Drug consumption in Norway 1996–2000 [Legemiddelforbruket i Norge 1996–2000], Norwegian Medicinal Depot, Oslo Ronning M (2001) Drug consumption in Norway 1996–2000 [Legemiddelforbruket i Norge 1996–2000], Norwegian Medicinal Depot, Oslo
23.
go back to reference Ronning M, Sanner T, Boe GH, Litleskare I, Strøm H, Granum T (2005) Drug consumption in Norway 2000–2004 [Legemiddelforbruket i Norge 2000–2004], Norwegian Institute of Public Health, Oslo Ronning M, Sanner T, Boe GH, Litleskare I, Strøm H, Granum T (2005) Drug consumption in Norway 2000–2004 [Legemiddelforbruket i Norge 2000–2004], Norwegian Institute of Public Health, Oslo
24.
go back to reference Oydvin K, Ronning M, Sakshaug S, Blix H, Ullerud T (1997) Drug consumption in Norway 1992–1996 [Legemiddelforbruket i Norge 1992–1996], Norsk Medisinaldepot AS, Oslo Oydvin K, Ronning M, Sakshaug S, Blix H, Ullerud T (1997) Drug consumption in Norway 1992–1996 [Legemiddelforbruket i Norge 1992–1996], Norsk Medisinaldepot AS, Oslo
27.
go back to reference Reith DM, Fountain J, McDowell R, Tilyard M (2003) Comparison of the fatal toxicity index of zopiclone with benzodiazepines. J Toxicol Clin Toxicol 41:975–980PubMedCrossRef Reith DM, Fountain J, McDowell R, Tilyard M (2003) Comparison of the fatal toxicity index of zopiclone with benzodiazepines. J Toxicol Clin Toxicol 41:975–980PubMedCrossRef
28.
go back to reference Hilberg T, Rogde S, Morland J (1999) Postmortem drug redistribution—human cases related to results in experimental animals. J Forensic Sci 44:3–9PubMed Hilberg T, Rogde S, Morland J (1999) Postmortem drug redistribution—human cases related to results in experimental animals. J Forensic Sci 44:3–9PubMed
29.
go back to reference Hilberg T, Morland J, Bjorneboe A (1994) Postmortem release of amitriptyline from the lungs; a mechanism of postmortem drug redistribution. Forensic Sci Int 64:47–55PubMedCrossRef Hilberg T, Morland J, Bjorneboe A (1994) Postmortem release of amitriptyline from the lungs; a mechanism of postmortem drug redistribution. Forensic Sci Int 64:47–55PubMedCrossRef
30.
go back to reference Pelissier-Alicot AL, Gaulier JM, Dupuis C et al (2006) Post-mortem redistribution of three beta-blockers in the rabbit. Int J Legal Med 120:226–232PubMedCrossRef Pelissier-Alicot AL, Gaulier JM, Dupuis C et al (2006) Post-mortem redistribution of three beta-blockers in the rabbit. Int J Legal Med 120:226–232PubMedCrossRef
31.
go back to reference Schulz M, Schmoldt A (1997) Therapeutic and toxic blood concentrations of more than 500 drugs. Pharmazie 52:895–911PubMed Schulz M, Schmoldt A (1997) Therapeutic and toxic blood concentrations of more than 500 drugs. Pharmazie 52:895–911PubMed
32.
go back to reference Olsen H, Koppang E, Alvan G, Morland J (1994) Carisoprodol elimination in humans. Ther Drug Monit 16:337–340PubMedCrossRef Olsen H, Koppang E, Alvan G, Morland J (1994) Carisoprodol elimination in humans. Ther Drug Monit 16:337–340PubMedCrossRef
33.
go back to reference Bramness JG, Skurtveit S, Gulliksen M, Breilid H, Steen VM, Morland J (2005) The CYP2C19 genotype and the use of oral contraceptives influence the pharmacokinetics of carisoprodol in healthy human subjects. Eur J Clin Pharmacol 61:499–506PubMedCrossRef Bramness JG, Skurtveit S, Gulliksen M, Breilid H, Steen VM, Morland J (2005) The CYP2C19 genotype and the use of oral contraceptives influence the pharmacokinetics of carisoprodol in healthy human subjects. Eur J Clin Pharmacol 61:499–506PubMedCrossRef
34.
go back to reference Woods JH, Katz JL, Winger G (1992) Benzodiazepines: use, abuse, and consequences. Pharmacol Rev 44:151–347PubMed Woods JH, Katz JL, Winger G (1992) Benzodiazepines: use, abuse, and consequences. Pharmacol Rev 44:151–347PubMed
35.
go back to reference Steentoft A, Teige B, Ceder G et al (2001) Fatal poisoning in drug addicts in the Nordic countries. Forensic Sci Int 123:63–69PubMedCrossRef Steentoft A, Teige B, Ceder G et al (2001) Fatal poisoning in drug addicts in the Nordic countries. Forensic Sci Int 123:63–69PubMedCrossRef
36.
go back to reference Jonsson A, Holmgren P, Ahlner J (2004) Fatal intoxications in a Swedish forensic autopsy material during 1992–2002. Forensic Sci Int 143:53–59PubMedCrossRef Jonsson A, Holmgren P, Ahlner J (2004) Fatal intoxications in a Swedish forensic autopsy material during 1992–2002. Forensic Sci Int 143:53–59PubMedCrossRef
37.
go back to reference Morland J (2000) Driving under the influence of medication and various substances other than alcohol [Kjøring under påvirkning av medikamenter og andre rusmidler enn alkohol]. Tidsskr Nor Laegeforen 120:2148–2150PubMed Morland J (2000) Driving under the influence of medication and various substances other than alcohol [Kjøring under påvirkning av medikamenter og andre rusmidler enn alkohol]. Tidsskr Nor Laegeforen 120:2148–2150PubMed
38.
go back to reference Meel BL (2004) Incidence and patterns of violent and/or traumatic deaths between 1993 and 1999 in the Transkei region of South Africa. J Trauma 57:125–129PubMedCrossRef Meel BL (2004) Incidence and patterns of violent and/or traumatic deaths between 1993 and 1999 in the Transkei region of South Africa. J Trauma 57:125–129PubMedCrossRef
39.
go back to reference Qin P, Agerbo E, Westergard-Nielsen N, Eriksson T, Mortensen PB (2000) Gender differences in risk factors for suicide in Denmark. Br J Psychiatry 177:546–550PubMedCrossRef Qin P, Agerbo E, Westergard-Nielsen N, Eriksson T, Mortensen PB (2000) Gender differences in risk factors for suicide in Denmark. Br J Psychiatry 177:546–550PubMedCrossRef
40.
go back to reference Demetriades D, Gkiokas G, Velmahos GC, Brown C, Murray J, Noguchi T (2004) Alcohol and illicit drugs in traumatic deaths: prevalence and association with type and severity of injuries. J Am Coll Surg 199:687–692PubMedCrossRef Demetriades D, Gkiokas G, Velmahos GC, Brown C, Murray J, Noguchi T (2004) Alcohol and illicit drugs in traumatic deaths: prevalence and association with type and severity of injuries. J Am Coll Surg 199:687–692PubMedCrossRef
41.
go back to reference Bramness JG, Skurtveit S, Grung M, Morland J (2000) Centrally acting muscle relaxants and traffic hazards [Sentralt virkende muskelrelakserende midler i trafikken]. Tidsskr Nor Laegeforen 120:1966–1969PubMed Bramness JG, Skurtveit S, Grung M, Morland J (2000) Centrally acting muscle relaxants and traffic hazards [Sentralt virkende muskelrelakserende midler i trafikken]. Tidsskr Nor Laegeforen 120:1966–1969PubMed
42.
go back to reference Substance Abuse and Mental Health Service Administration (2003) Emergency department trends from the drug abuse warning network, final estimates 1995–2002. DAWN Series D-24, Rockville, MD Substance Abuse and Mental Health Service Administration (2003) Emergency department trends from the drug abuse warning network, final estimates 1995–2002. DAWN Series D-24, Rockville, MD
43.
go back to reference Koski A, Vuori E, Ojanpera I (2005) Newer antidepressants: evaluation of fatal toxicity index and interaction with alcohol based on Finnish postmortem data. Int J Legal Med 119:344–348PubMedCrossRef Koski A, Vuori E, Ojanpera I (2005) Newer antidepressants: evaluation of fatal toxicity index and interaction with alcohol based on Finnish postmortem data. Int J Legal Med 119:344–348PubMedCrossRef
Metadata
Title
Carisoprodol intoxications: a retrospective study of forensic autopsy material from 1992–2003
Authors
Gudrun Høiseth
Jørgen G. Bramness
Asbjørg S. Christophersen
Jørg Mørland
Publication date
01-09-2007
Publisher
Springer-Verlag
Published in
International Journal of Legal Medicine / Issue 5/2007
Print ISSN: 0937-9827
Electronic ISSN: 1437-1596
DOI
https://doi.org/10.1007/s00414-006-0139-1

Other articles of this Issue 5/2007

International Journal of Legal Medicine 5/2007 Go to the issue